Author:
Fok Henry,Teck Khong,Phizackerley David
Subject
Pharmacology (medical),General Medicine
Reference6 articles.
1. Pathways to faster access to medicines
2. Available tools to facilitate early patient access to medicines in the EU and the USA: analysis of conditional approvals and the implications for personalized medicine;Leyens;Public Health Genomics,2015
3. European Medicines Agency, 2018. Conditional marketing authorisation [online]. Available: https://www.ema.europa.eu/en/human-regulatory/marketing-authorisation/conditional-marketing-authorisation [Accessed 1 October 2018].
4. European Medicines Agency, 2018. Guideline on the scientific application and the practical arrangements necessary to implement Commission Regulation (EC) No 507/2006 on the conditional marketing authorisation for medicinal products for human use falling within the scope of Regulation (EC) No 726/2004 [online]. Available: http://www.ema.europa.eu/docs/en_GB/document_library/Scientific_guideline/2016/03/WC500202774.pdf [Accessed 1 October 2018].
5. Mostaghim SR et al . Safety related label changes for new drugs after approval in the US through expedited regulatory pathways: retrospective cohort study. BMJ 2017; 358: j3837